Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Before investing in cryptocurrency, it's crucial to understand the market. Learn key insights to prepare yourself for potential investments.
24,812 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
New labor data reveals a troubling disconnect: participation falls while unemployment headlines stay resilient. Inves...
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
A hypothetical scenario examines how a presidential message could ripple markets, driving oil spikes, safe-haven trad...
New high‑voltage lines aimed at powering AI data centers are igniting clashes from rural Pennsylvania to middle Ameri...
A growing number of couples are missing coordinated claiming strategies, shaving hundreds of dollars from lifetime So...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...
The allianz 2025 annual retirement study reveals a 13-point drop in confidence since 2020. Inflation and rising housi...
As inflation reaccelerates, a potential rate hike under a new Fed chair could complicate Trump’s midterm plans and ri...